Menu
GeneBe

rs8176330

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000468682.2(HRAS):c.-54+1055C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0957 in 152,160 control chromosomes in the GnomAD database, including 958 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.096 ( 958 hom., cov: 33)

Consequence

HRAS
ENST00000468682.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.269
Variant links:
Genes affected
HRAS (HGNC:5173): (HRas proto-oncogene, GTPase) This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LRRC56XM_011519875.3 linkuse as main transcriptc.-424-2800G>A intron_variant
LRRC56XM_011519877.3 linkuse as main transcriptc.-161-3782G>A intron_variant
LRRC56XM_017017167.2 linkuse as main transcriptc.-499-2725G>A intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HRASENST00000468682.2 linkuse as main transcriptc.-54+1055C>T intron_variant 3
HRASENST00000462734.2 linkuse as main transcriptc.-54+538C>T intron_variant, NMD_transcript_variant 2

Frequencies

GnomAD3 genomes
AF:
0.0957
AC:
14548
AN:
152052
Hom.:
955
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0261
Gnomad AMI
AF:
0.0846
Gnomad AMR
AF:
0.187
Gnomad ASJ
AF:
0.101
Gnomad EAS
AF:
0.00174
Gnomad SAS
AF:
0.0366
Gnomad FIN
AF:
0.0780
Gnomad MID
AF:
0.0287
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.103
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0957
AC:
14555
AN:
152160
Hom.:
958
Cov.:
33
AF XY:
0.0934
AC XY:
6950
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.0260
Gnomad4 AMR
AF:
0.188
Gnomad4 ASJ
AF:
0.101
Gnomad4 EAS
AF:
0.00174
Gnomad4 SAS
AF:
0.0369
Gnomad4 FIN
AF:
0.0780
Gnomad4 NFE
AF:
0.132
Gnomad4 OTH
AF:
0.102
Alfa
AF:
0.120
Hom.:
166
Bravo
AF:
0.101
Asia WGS
AF:
0.0310
AC:
106
AN:
3460

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
Cadd
Benign
5.6
Dann
Benign
0.76

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs8176330; hg19: chr11-535798; API